Frequency of tumor recurrence

A strong predictor of stage progression in initially diagnosed nonmuscle invasive bladder cancer

Nobuyuki Tanaka, Eiji Kikuchi, Kazuhiro Matsumoto, Akira Miyajima, Ken Nakagawa, Mototsugu Oya

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose Patients with nonmuscle invasive bladder cancer usually experience multiple instances of tumor recurrence until stage progression occurs. However, it has not yet been fully evaluated whether the timing and/or pattern of tumor recurrence could affect subsequent stage progression. We examined whether the frequency of tumor recurrence provides additional predictive information concerning stage progression. Materials and Methods A total of 484 patients with initially diagnosed nonmuscle invasive bladder cancer were identified between 1985 and 2006 at our institution. Median followup was 7.2 years. Frequency of tumor recurrence was analyzed to determine if it affected subsequent stage progression. Results Of these patients 40 (8.3%) experienced stage progression during followup. Using Kaplan-Meier analysis subsequent stage progression could be most strongly predicted in patients with a recurrence rate of 1 or more per year during the first 2 years, although similar results were observed for various cutoff periods and recurrence rates. The 10-year progression-free survival rate was 58.0% in patients with a recurrence rate of 1 or more per year and 93.3% in their counterparts (p <0.001). Multivariate analysis demonstrated that the appearance of tumor grade 3 (p = 0.027, risk ratio 2.36), carcinoma in situ (p = 0.045, risk ratio 2.44) and a recurrence rate of 1 or more per year during the first 2 years (p <0.001, risk ratio 7.40) were independent risk factors for subsequent stage progression. Conclusions Frequency of tumor recurrence is a strong predictor of subsequent stage progression in patients initially diagnosed with nonmuscle invasive bladder cancer. More appropriate followup and aggressive treatment due to a higher malignant potential for stage progression might be recommended in patients with a recurrence rate of 1 or more per year during the first 2 years.

Original languageEnglish
Pages (from-to)450-455
Number of pages6
JournalJournal of Urology
Volume185
Issue number2
DOIs
Publication statusPublished - 2011 Feb

Fingerprint

Urinary Bladder Neoplasms
Recurrence
Neoplasms
Odds Ratio
Carcinoma in Situ
Kaplan-Meier Estimate
Disease-Free Survival
Multivariate Analysis
Survival Rate

Keywords

  • disease progression
  • recurrence
  • urinary bladder neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Frequency of tumor recurrence : A strong predictor of stage progression in initially diagnosed nonmuscle invasive bladder cancer. / Tanaka, Nobuyuki; Kikuchi, Eiji; Matsumoto, Kazuhiro; Miyajima, Akira; Nakagawa, Ken; Oya, Mototsugu.

In: Journal of Urology, Vol. 185, No. 2, 02.2011, p. 450-455.

Research output: Contribution to journalArticle

@article{78fa2253724f4201aa5aca8edf19a797,
title = "Frequency of tumor recurrence: A strong predictor of stage progression in initially diagnosed nonmuscle invasive bladder cancer",
abstract = "Purpose Patients with nonmuscle invasive bladder cancer usually experience multiple instances of tumor recurrence until stage progression occurs. However, it has not yet been fully evaluated whether the timing and/or pattern of tumor recurrence could affect subsequent stage progression. We examined whether the frequency of tumor recurrence provides additional predictive information concerning stage progression. Materials and Methods A total of 484 patients with initially diagnosed nonmuscle invasive bladder cancer were identified between 1985 and 2006 at our institution. Median followup was 7.2 years. Frequency of tumor recurrence was analyzed to determine if it affected subsequent stage progression. Results Of these patients 40 (8.3{\%}) experienced stage progression during followup. Using Kaplan-Meier analysis subsequent stage progression could be most strongly predicted in patients with a recurrence rate of 1 or more per year during the first 2 years, although similar results were observed for various cutoff periods and recurrence rates. The 10-year progression-free survival rate was 58.0{\%} in patients with a recurrence rate of 1 or more per year and 93.3{\%} in their counterparts (p <0.001). Multivariate analysis demonstrated that the appearance of tumor grade 3 (p = 0.027, risk ratio 2.36), carcinoma in situ (p = 0.045, risk ratio 2.44) and a recurrence rate of 1 or more per year during the first 2 years (p <0.001, risk ratio 7.40) were independent risk factors for subsequent stage progression. Conclusions Frequency of tumor recurrence is a strong predictor of subsequent stage progression in patients initially diagnosed with nonmuscle invasive bladder cancer. More appropriate followup and aggressive treatment due to a higher malignant potential for stage progression might be recommended in patients with a recurrence rate of 1 or more per year during the first 2 years.",
keywords = "disease progression, recurrence, urinary bladder neoplasms",
author = "Nobuyuki Tanaka and Eiji Kikuchi and Kazuhiro Matsumoto and Akira Miyajima and Ken Nakagawa and Mototsugu Oya",
year = "2011",
month = "2",
doi = "10.1016/j.juro.2010.09.087",
language = "English",
volume = "185",
pages = "450--455",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Frequency of tumor recurrence

T2 - A strong predictor of stage progression in initially diagnosed nonmuscle invasive bladder cancer

AU - Tanaka, Nobuyuki

AU - Kikuchi, Eiji

AU - Matsumoto, Kazuhiro

AU - Miyajima, Akira

AU - Nakagawa, Ken

AU - Oya, Mototsugu

PY - 2011/2

Y1 - 2011/2

N2 - Purpose Patients with nonmuscle invasive bladder cancer usually experience multiple instances of tumor recurrence until stage progression occurs. However, it has not yet been fully evaluated whether the timing and/or pattern of tumor recurrence could affect subsequent stage progression. We examined whether the frequency of tumor recurrence provides additional predictive information concerning stage progression. Materials and Methods A total of 484 patients with initially diagnosed nonmuscle invasive bladder cancer were identified between 1985 and 2006 at our institution. Median followup was 7.2 years. Frequency of tumor recurrence was analyzed to determine if it affected subsequent stage progression. Results Of these patients 40 (8.3%) experienced stage progression during followup. Using Kaplan-Meier analysis subsequent stage progression could be most strongly predicted in patients with a recurrence rate of 1 or more per year during the first 2 years, although similar results were observed for various cutoff periods and recurrence rates. The 10-year progression-free survival rate was 58.0% in patients with a recurrence rate of 1 or more per year and 93.3% in their counterparts (p <0.001). Multivariate analysis demonstrated that the appearance of tumor grade 3 (p = 0.027, risk ratio 2.36), carcinoma in situ (p = 0.045, risk ratio 2.44) and a recurrence rate of 1 or more per year during the first 2 years (p <0.001, risk ratio 7.40) were independent risk factors for subsequent stage progression. Conclusions Frequency of tumor recurrence is a strong predictor of subsequent stage progression in patients initially diagnosed with nonmuscle invasive bladder cancer. More appropriate followup and aggressive treatment due to a higher malignant potential for stage progression might be recommended in patients with a recurrence rate of 1 or more per year during the first 2 years.

AB - Purpose Patients with nonmuscle invasive bladder cancer usually experience multiple instances of tumor recurrence until stage progression occurs. However, it has not yet been fully evaluated whether the timing and/or pattern of tumor recurrence could affect subsequent stage progression. We examined whether the frequency of tumor recurrence provides additional predictive information concerning stage progression. Materials and Methods A total of 484 patients with initially diagnosed nonmuscle invasive bladder cancer were identified between 1985 and 2006 at our institution. Median followup was 7.2 years. Frequency of tumor recurrence was analyzed to determine if it affected subsequent stage progression. Results Of these patients 40 (8.3%) experienced stage progression during followup. Using Kaplan-Meier analysis subsequent stage progression could be most strongly predicted in patients with a recurrence rate of 1 or more per year during the first 2 years, although similar results were observed for various cutoff periods and recurrence rates. The 10-year progression-free survival rate was 58.0% in patients with a recurrence rate of 1 or more per year and 93.3% in their counterparts (p <0.001). Multivariate analysis demonstrated that the appearance of tumor grade 3 (p = 0.027, risk ratio 2.36), carcinoma in situ (p = 0.045, risk ratio 2.44) and a recurrence rate of 1 or more per year during the first 2 years (p <0.001, risk ratio 7.40) were independent risk factors for subsequent stage progression. Conclusions Frequency of tumor recurrence is a strong predictor of subsequent stage progression in patients initially diagnosed with nonmuscle invasive bladder cancer. More appropriate followup and aggressive treatment due to a higher malignant potential for stage progression might be recommended in patients with a recurrence rate of 1 or more per year during the first 2 years.

KW - disease progression

KW - recurrence

KW - urinary bladder neoplasms

UR - http://www.scopus.com/inward/record.url?scp=78651327152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651327152&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2010.09.087

DO - 10.1016/j.juro.2010.09.087

M3 - Article

VL - 185

SP - 450

EP - 455

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -